Our BriDGE technology transforms widely available intact collagen tissue into a stabilized collagen matrix that activates, supports and accelerates the patient’s own healing cascade. A landmark study published by the Regenerative Medicine Center at the Ohio State University reported that BriDGE-processed collagen recruited host growth factors while also upregulating the host’s natural immune system to prevent biofilm formation.
CREATING A STABILIZED ACELLULAR COLLAGEN MATRIX
Our BriDGE® technology is a patented method to treat intact tissue, sourced from animals or humans, to create a collagen matrix with the following properties:
Extremely bio-friendly when put in contact with damaged ligaments and tendon … no long-term inflammatory response;
Recruits and supports the patient’s own growth factors directly at the wound site … 24/7;
The patient’s own growth factors are perfectly designed to stimulate cell proliferation, wound healing and cellular differentiation;
The BriDGE® technology also stabilizes the collagen matrix to prevent premature degradation … it is there to support tissue regeneration until the wound heals.